Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces chronic colonic inflammation in rats

This publication has 45 references indexed in Scilit:

• Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic
  The FASEB Journal, 2004
• Resveratrol, a polyphenol found in grapes, suppresses oxidative damage and stimulates apoptosis during early colonic inflammation in rats
  Biochemical Pharmacology, 2004
• A new flavonoid derivative, dosmalfate, attenuates the development of dextran sulphate sodium-induced colitis in mice
  International Immunopharmacology, 2003
• Novel approaches to treating inflammatory bowel disease: targeting alpha-4 integrin
  American Journal of Gastroenterology, 2003
• The cyclo-oxygenase-2 inhibitor, rofecoxib, attenuates mucosal damage due to colitis induced by trinitrobenzene sulphonic acid in rats
  European Journal of Pharmacology, 2003
• Antiadhesion Molecule Therapy in Inflammatory Bowel Disease
  Inflammatory Bowel Diseases, 2002
• Cyclooxygenase-2-derived prostaglandin D₂is an early anti-inflammatory signal in experimental colitis
  American Journal of Physiology-Gastrointestinal and Liver Physiology, 2000
• Inducible cyclooxygenase may have anti-inflammatory properties
  Nature Medicine, 1999
• Prostaglandins prevent decreased epithelial cell proliferation associated with dextran sodium sulfate injury in mice
  Gastroenterology, 1998
• Misoprostol provides a colonic mucosal protective effect during acetic acid-induced colitis in rats
  Gastroenterology, 1990